Ascencia raises seed capital investment for further development of their lab digitization technology

UTRECHT, Netherlands – Utrecht Health Seed Fund and imec.istart invest 300K+ euros in Ascenscia.   Ascenscia is an emerging tech startup in laboratory automation. Their product comprises a highly specialized voice assistant for scientific laboratories. It understands scientific terminologies and workflows efficiently and enables scientists to communicate with other lab

Synerkine Pharma secures EUR 12.1 million to accelerate novel pain therapeutics towards clinical proof-of-concept

Our new portfolio company Synerkine Pharma, a biopharmaceutical company creating innovative pain solutions. Leiden, the Netherlands, October 12, 2023 ·     Flerie leads Series A extension with other existing investor Thuja Capital participating and NEW investors InnovationQuarter Capital and Utrecht Health Seed Fund joining the round ·     Complementing the Series a

Academic Startup Competition – 4th Edition – APPLICATIONS OPEN

Dear Founder, We are excited to announce that the applications for the 4th edition of the Academic Startup Competition are open! The Academic Startup Competition (ASC) is a joint initiative of Techleap, UNL, NFU, NAE, UTwente, VU and EZK. The competition offers a curated batch of 20 selected academic startups

UMC Utrecht spin-out Cordys Analytics secures investment for improved early detection of heart disease.

UTRECHT, Netherlands – 3 oktober 2023 LUMO Labs, ROM Utrecht Region and Utrecht Health Seed Fund are investing 900,000 euros in Cordys Analytics. The startup is a Dutch healthtech spin-out from the University Medical Center Utrecht (UMCU) and incubated at UtrechtInc.   Cordys Analytics’ AI-powered software platform for electrocardiogram analysis

Phlox Therapeutics Raises Additional Seed Funding to Further Develop RNA Therapies for Genetic Laminopathies

A very warm welcome to new portfolio company Phlox Therapeutics, a private biotechnology company specializing in developing innovative RNA-therapeutics for rare genetic cardiomyopathies. Below the press relaese; • Phlox Therapeutics raises additional seed funding to develop RNA therapies for genetic laminopathies • Funds will advance the company’s lead program into preclinical

Valentina Vignali appointed as Investment Associate

Utrecht Holdings welcomes Valentina Vignali to the team. Valentina is about to obtain a PhD in Biomedical Engineering from the University of Groningen and brings experience from working in academia and venture capital. At her previous roles she conducted fund and direct investments due diligence. Valentina will support the business

Looking for an Investment Analyst

Bringing new innovations to the market; that is the challenge that we, together with researchers from Utrecht University and UMC Utrecht, face every day at Utrecht Holdings. The goal of our team of 15 expert and enthusiastic employees, is to maximize the impact of academic research on people, society and

Timo Koopmans appointed as new Investment Manager of Utrecht Health Seed Fund

The Utrecht Health Seed Fund is happy to announce the start of its new Investment Manager: Timo Koopmans. Timo holds a PhD in medicinal chemistry from Utrecht University and as a startup founder himself, understands the challenges young companies face. Furthermore he has experience at a management & innovation consultancy


Utrecht Health Seed Fund’s first anniversary!

Before we knew, we’re celebrating Utrecht Health Seed Fund’s…

SentryX closes €3.2M seed funding round for the development of next generation pain relief therapeutics

We are delighted with the new investment in SentryX, a next generation,…

TargED Biopharmaceuticals appoints Ludo Haazen, M.D. as Chief Medical Officer

TargED Biopharmaceuticals, a biotech spin-off of the University…

NTrans Technologies closes Series A investment to accelerate development of gene editing therapy

We're excited to be investing in NTrans Technologies BV, a gene…

Moveshelf closes seed investment to accelerate digital transformation of diagnosis and care for movement disorders

We proudly announce UHSF's second investment, in Moveshelf, together…

TargED receives NWO Take-Off 2

Congratulations to the team of our portfolio company TargED Biopharmaceuticals,…

ROM Regio Utrecht Launched

The Regional Development Fund (Regionale Ontwikkelingsmaatschappij…

New Utrecht-based fund investing in Life Science & Health start-ups

The Utrecht Health Seed Fund (UHSF) officially launched at…